Female gender is associated with long COVID syndrome: a prospective cohort study
| Autor: | Daniele Tomasoni, Roberto Castoldi, Gianmarco Tagliaferri, Alessandro Tavelli, Giulia Marchetti, Antonella d'Arminio Monforte, Giovanni Mulè, Debora Mondatore, Kyrie Piscopo, Marina Allegrini, Daniele Tesoro, Ottavia Viganò, Chiara Luridiana Battistini, Elisa Suardi, Tomaso Beringheli, Elena Vegni, Diletta Barbanotti, Camilla Falcinella, Matteo Augello, Francesca Bai, Andrea Cona, Stefano Terzoni, Benedetta Varisco, Camilla Tincati |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty Long COVID Coronavirus disease 2019 (COVID-19) Disease Logistic regression Post-Acute COVID-19 Syndrome Internal medicine medicine Humans Prospective Studies Symptom onset Prospective cohort study Pathological Depression (differential diagnoses) SARS-CoV-2 business.industry COVID-19 Gender post-COVID syndrome General Medicine Respiration Artificial Infectious Diseases Anxiety Original Article Female medicine.symptom business |
| Zdroj: | Clinical Microbiology and Infection |
| ISSN: | 1198-743X |
| DOI: | 10.1016/j.cmi.2021.11.002 |
| Popis: | Objective We explored the association between female gender and “long COVID” syndrome, defined as persistence of physical and/or psychological symptoms for more than 4 weeks after recovery from acute COVID-19 disease. Secondary aim was to identify predictors of “long COVID” syndrome by multivariable logistic regression analysis. Methods This is a single-centre prospective cohort study conducted at San Paolo Hospital in Milan, Italy. We enrolled adult patients that were evaluated at the post-COVID outpatient service of our Infectious Diseases Unit between April 15th 2020 and December 15th 2020. Participants were individuals who had clinically recovered from COVID-19 and in whom virological clearance had occurred. Previous infection by SARS-CoV-2 was microbiologically documented by positivity at reverse-transcriptase polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab. All enrolled patients underwent blood tests and a comprehensive medical examination at follow-up. Individuals were interviewed about resolved and persisting symptoms and were asked to fill in two questionnaires to allow assessment of the Hospital Anxiety and Depression symptoms (HADS) score and of the Impact of Event Scale–Revised (IES-R) score. Results A total of 377 patients were enrolled in the study. The median time from symptom onset to clinical recovery and virological clearance was 79 (IQR 69-102) and 56 (IQR 47-74) days, respectively. A diagnosis of “long COVID” syndrome was made in 260/377 (69%) patients. The most common reported symptoms were fatigue (149/377, 39.5%), exertional dyspnoea (109/377, 28.9%), musculoskeletal pain (80/377, 21.2%) and “brain fog” (76/377, 20.2%). Anxiety symptoms were ascertained in 71/377 (18.8%) individuals, whereas 40/377 (10.6%) patients presented symptoms of depression. Post-traumatic stress disorder (defined by a pathological IES-R score) was diagnosed in one-third of patients (85/275, 31%). Female gender was independently associated with “long COVID” syndrome at multivariable analysis (AOR 3.3 versus males, 95%CI 1.8-6.2, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|